1330-CAR-NK Cell Therapy: Breakthroughs and Challenges
The paper explores the development and clinical application of chimeric antigen receptor (CAR)-engineered natural killer (NK) cells as a transformative immunotherapy for cancer. While CAR-T cell therapy has succeeded in treating blood cancers, it faces hurdles in solid tumors due to high toxicity and complex manufacturing requirements. In contrast, CAR-NK cells offer a safer, more accessible "off-the-shelf" alternative that leverages the innate ability of NK cells to destroy malignant tissues without causing severe side effects like graft-versus-host disease. Despite this potential, the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.